{"id":23775,"date":"2025-07-15T05:00:00","date_gmt":"2025-07-15T10:00:00","guid":{"rendered":"https:\/\/tiro.expert\/?p=23775"},"modified":"2025-07-15T05:00:00","modified_gmt":"2025-07-15T10:00:00","slug":"unresectable-vs-resectable-thyroid-cancer-pt-2","status":"publish","type":"post","link":"https:\/\/tiro.expert\/es\/2025\/07\/unresectable-vs-resectable-thyroid-cancer-pt-2\/","title":{"rendered":"C\u00e1ncer de tiroides irresecable frente a resecable (2\u00aa parte)"},"content":{"rendered":"<p><iframe loading=\"lazy\" allowtransparency=\"true\" height=\"150\" width=\"100%\" style=\"border: none;\" scrolling=\"no\" data-name=\"pb-iframe-player\" src=\"https:\/\/www.podbean.com\/player-v2\/?share=1&#038;download=0&#038;rtl=0&#038;fonts=Arial&#038;skin=654771&#038;btn-skin=654771&#038;multiple_size=315&#038;square_size=300&#038;order=episodic&#038;filter=all&#038;limit=10&#038;season=all&#038;tag=all&#038;font-color=auto&#038;logo_link=podcast_page&#038;i=757bf-18bd88a-pb\"><\/iframe><\/p>\n<p><span style=\"font-weight:400;\">\u00bfQu\u00e9 cambia cuando tumores tiroideos antes considerados inoperables se convierten en candidatos quir\u00fargicos? <strong>El Dr. Mark Zafereo se une a la Dra. Dana Hartl para explorar c\u00f3mo la terapia neoadyuvante modifica el momento quir\u00fargico, la toma de decisiones y la atenci\u00f3n a largo plazo de los pacientes con c\u00e1ncer de tiroides agresivo.<\/strong> Este debate desvela juicios de valor cl\u00ednicos, perspectivas de imagen y estrategias quir\u00fargicas en evoluci\u00f3n que no querr\u00e1 perderse.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>\u00bfQu\u00e9 cambia cuando los tumores tiroideos que antes se consideraban inoperables se convierten en candidatos quir\u00fargicos? El Dr. Mark Zafereo se une a la Dra. Dana Hartl para explorar c\u00f3mo la terapia neoadyuvante modifica el momento quir\u00fargico, la toma de decisiones y la atenci\u00f3n a largo plazo de los pacientes con c\u00e1ncer de tiroides agresivo. Este debate revela juicios de valor cl\u00ednicos, perspectivas de imagen y estrategias quir\u00fargicas en evoluci\u00f3n que no querr\u00e1 perderse.<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-23775","post","type-post","status-publish","format-standard","hentry","category-uncategorized","tw-post-no-content"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO Pro 5.0.5.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"What changes when thyroid tumors once considered inoperable become surgical candidates? Dr. Mark Zafereo joins Dr. Dana Hartl to explore how neoadjuvant therapy reshapes surgical timing, decision-making, and long-term care for patients with aggressive thyroid cancer. This discussion uncovers clinical judgment calls, imaging insights &amp; evolving surgical strategies you won&#039;t want to miss.\" \/>\n\t<meta name=\"robots\" content=\"nosnippet, max-image-preview:large, max-video-preview:-1\" \/>\n\t<meta name=\"author\" content=\"THANC Foundation\"\/>\n\t<meta name=\"google-site-verification\" content=\"dgn_KNbWOqdQMThGOuzuLswqwKwBsjcS82PzbL7RTr4\" \/>\n\t<meta name=\"msvalidate.01\" content=\"665B47E811A7F57E1C97131210D3FD3A\" \/>\n\t<meta name=\"keywords\" content=\"uncategorized\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/tiro.expert\/es\/2025\/07\/unresectable-vs-resectable-thyroid-cancer-pt-2\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO Pro (AIOSEO) 5.0.5.1\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/tiro.expert\\\/es\\\/2025\\\/07\\\/unresectable-vs-resectable-thyroid-cancer-pt-2\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/tiro.expert\\\/es\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/tiro.expert\\\/es\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/tiro.expert\\\/es\\\/category\\\/uncategorized\\\/#listItem\",\"name\":\"Uncategorized\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/tiro.expert\\\/es\\\/category\\\/uncategorized\\\/#listItem\",\"position\":2,\"name\":\"Uncategorized\",\"item\":\"https:\\\/\\\/tiro.expert\\\/es\\\/category\\\/uncategorized\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/tiro.expert\\\/es\\\/2025\\\/07\\\/unresectable-vs-resectable-thyroid-cancer-pt-2\\\/#listItem\",\"name\":\"Unresectable vs. Resectable Thyroid Cancer (Pt. 2)\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/tiro.expert\\\/es\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/tiro.expert\\\/es\\\/2025\\\/07\\\/unresectable-vs-resectable-thyroid-cancer-pt-2\\\/#listItem\",\"position\":3,\"name\":\"Unresectable vs. Resectable Thyroid Cancer (Pt. 2)\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/tiro.expert\\\/es\\\/category\\\/uncategorized\\\/#listItem\",\"name\":\"Uncategorized\"}}]},{\"@type\":\"Course\",\"@id\":\"https:\\\/\\\/tiro.expert\\\/es\\\/2025\\\/07\\\/unresectable-vs-resectable-thyroid-cancer-pt-2\\\/#course\",\"name\":\"Unresectable vs. Resectable Thyroid Cancer (Pt. 2)\",\"description\":\"What changes when thyroid tumors once considered inoperable become surgical candidates? Dr. Mark Zafereo joins Dr. Dana Hartl to explore how neoadjuvant therapy reshapes surgical timing, decision-making, and long-term care for patients with aggressive thyroid cancer. This discussion uncovers clinical judgment calls, imaging insights & evolving surgical strategies you won't want to miss.\",\"datePublished\":\"2025-07-15\",\"provider\":{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/tiro.expert\\\/es\\\/#organization\"}},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/tiro.expert\\\/es\\\/#organization\",\"name\":\"Thyroid Int'l Recommendations Online (TIRO)\",\"description\":\"Thyroid Int'l Recommendations Online\",\"url\":\"https:\\\/\\\/tiro.expert\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/tiro.expert\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/TIRO-secondary-logo-siteID.png\",\"@id\":\"https:\\\/\\\/tiro.expert\\\/es\\\/2025\\\/07\\\/unresectable-vs-resectable-thyroid-cancer-pt-2\\\/#organizationLogo\",\"width\":847,\"height\":278,\"caption\":\"TIRO Thyroid International Recommendations Online secondary logo\"},\"image\":{\"@id\":\"https:\\\/\\\/tiro.expert\\\/es\\\/2025\\\/07\\\/unresectable-vs-resectable-thyroid-cancer-pt-2\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/thancfoundation\",\"https:\\\/\\\/twitter.com\\\/thancfoundation\",\"https:\\\/\\\/instagram.com\\\/thancfoundation\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC4Y_bz_8BmgUU96NWdpBkdw\\\/feed\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/tiro.expert\\\/es\\\/author\\\/hncg2-admin\\\/#author\",\"url\":\"https:\\\/\\\/tiro.expert\\\/es\\\/author\\\/hncg2-admin\\\/\",\"name\":\"THANC Foundation\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/tiro.expert\\\/es\\\/2025\\\/07\\\/unresectable-vs-resectable-thyroid-cancer-pt-2\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a7a0d3017fb58318083321994a81ffc0be78bc1c2c039df03c936c365bab39fb?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"THANC Foundation\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/tiro.expert\\\/es\\\/2025\\\/07\\\/unresectable-vs-resectable-thyroid-cancer-pt-2\\\/#webpage\",\"url\":\"https:\\\/\\\/tiro.expert\\\/es\\\/2025\\\/07\\\/unresectable-vs-resectable-thyroid-cancer-pt-2\\\/\",\"name\":\"Unresectable vs. Resectable Thyroid Cancer (Pt. 2) \\u2023 TIRO\",\"description\":\"What changes when thyroid tumors once considered inoperable become surgical candidates? Dr. Mark Zafereo joins Dr. Dana Hartl to explore how neoadjuvant therapy reshapes surgical timing, decision-making, and long-term care for patients with aggressive thyroid cancer. This discussion uncovers clinical judgment calls, imaging insights & evolving surgical strategies you won't want to miss.\",\"inLanguage\":\"es-MX\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/tiro.expert\\\/es\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/tiro.expert\\\/es\\\/2025\\\/07\\\/unresectable-vs-resectable-thyroid-cancer-pt-2\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/tiro.expert\\\/es\\\/author\\\/hncg2-admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/tiro.expert\\\/es\\\/author\\\/hncg2-admin\\\/#author\"},\"datePublished\":\"2025-07-15T05:00:00-05:00\",\"dateModified\":\"2025-07-15T05:00:00-05:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/tiro.expert\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/tiro.expert\\\/es\\\/\",\"name\":\"TIRO\",\"description\":\"Thyroid Int'l Recommendations Online\",\"inLanguage\":\"es-MX\",\"publisher\":{\"@id\":\"https:\\\/\\\/tiro.expert\\\/es\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO Pro -->\r\n\t\t<title>Unresectable vs. Resectable Thyroid Cancer (Pt. 2) \u2023 TIRO<\/title>\n\n","aioseo_head_json":{"title":"C\u00e1ncer de tiroides irresecable frente a resecable (Pt. 2) \u2023 TIRO","description":"\u00bfQu\u00e9 cambia cuando los tumores tiroideos que antes se consideraban inoperables se convierten en candidatos quir\u00fargicos? El Dr. Mark Zafereo se une a la Dra. Dana Hartl para explorar c\u00f3mo la terapia neoadyuvante modifica el momento quir\u00fargico, la toma de decisiones y la atenci\u00f3n a largo plazo de los pacientes con c\u00e1ncer de tiroides agresivo. Este debate revela juicios de valor cl\u00ednicos, perspectivas de imagen y estrategias quir\u00fargicas en evoluci\u00f3n que no querr\u00e1 perderse.","canonical_url":"https:\/\/tiro.expert\/es\/2025\/07\/unresectable-vs-resectable-thyroid-cancer-pt-2\/","robots":"nosnippet, max-image-preview:large, max-video-preview:-1","keywords":"uncategorized","webmasterTools":{"google-site-verification":"dgn_KNbWOqdQMThGOuzuLswqwKwBsjcS82PzbL7RTr4","msvalidate.01":"665B47E811A7F57E1C97131210D3FD3A","miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/tiro.expert\/es\/2025\/07\/unresectable-vs-resectable-thyroid-cancer-pt-2\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/tiro.expert\/es\/#listItem","position":1,"name":"Home","item":"https:\/\/tiro.expert\/es\/","nextItem":{"@type":"ListItem","@id":"https:\/\/tiro.expert\/es\/category\/uncategorized\/#listItem","name":"Uncategorized"}},{"@type":"ListItem","@id":"https:\/\/tiro.expert\/es\/category\/uncategorized\/#listItem","position":2,"name":"Uncategorized","item":"https:\/\/tiro.expert\/es\/category\/uncategorized\/","nextItem":{"@type":"ListItem","@id":"https:\/\/tiro.expert\/es\/2025\/07\/unresectable-vs-resectable-thyroid-cancer-pt-2\/#listItem","name":"Unresectable vs. Resectable Thyroid Cancer (Pt. 2)"},"previousItem":{"@type":"ListItem","@id":"https:\/\/tiro.expert\/es\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/tiro.expert\/es\/2025\/07\/unresectable-vs-resectable-thyroid-cancer-pt-2\/#listItem","position":3,"name":"Unresectable vs. Resectable Thyroid Cancer (Pt. 2)","previousItem":{"@type":"ListItem","@id":"https:\/\/tiro.expert\/es\/category\/uncategorized\/#listItem","name":"Uncategorized"}}]},{"@type":"Course","@id":"https:\/\/tiro.expert\/es\/2025\/07\/unresectable-vs-resectable-thyroid-cancer-pt-2\/#course","name":"Unresectable vs. Resectable Thyroid Cancer (Pt. 2)","description":"What changes when thyroid tumors once considered inoperable become surgical candidates? Dr. Mark Zafereo joins Dr. Dana Hartl to explore how neoadjuvant therapy reshapes surgical timing, decision-making, and long-term care for patients with aggressive thyroid cancer. This discussion uncovers clinical judgment calls, imaging insights & evolving surgical strategies you won't want to miss.","datePublished":"2025-07-15","provider":{"@type":"Organization","@id":"https:\/\/tiro.expert\/es\/#organization"}},{"@type":"Organization","@id":"https:\/\/tiro.expert\/es\/#organization","name":"Thyroid Int'l Recommendations Online (TIRO)","description":"Thyroid Int'l Recommendations Online","url":"https:\/\/tiro.expert\/es\/","logo":{"@type":"ImageObject","url":"https:\/\/tiro.expert\/wp-content\/uploads\/2021\/01\/TIRO-secondary-logo-siteID.png","@id":"https:\/\/tiro.expert\/es\/2025\/07\/unresectable-vs-resectable-thyroid-cancer-pt-2\/#organizationLogo","width":847,"height":278,"caption":"TIRO Thyroid International Recommendations Online secondary logo"},"image":{"@id":"https:\/\/tiro.expert\/es\/2025\/07\/unresectable-vs-resectable-thyroid-cancer-pt-2\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/thancfoundation","https:\/\/twitter.com\/thancfoundation","https:\/\/instagram.com\/thancfoundation\/","https:\/\/www.youtube.com\/channel\/UC4Y_bz_8BmgUU96NWdpBkdw\/feed"]},{"@type":"Person","@id":"https:\/\/tiro.expert\/es\/author\/hncg2-admin\/#author","url":"https:\/\/tiro.expert\/es\/author\/hncg2-admin\/","name":"THANC Foundation","image":{"@type":"ImageObject","@id":"https:\/\/tiro.expert\/es\/2025\/07\/unresectable-vs-resectable-thyroid-cancer-pt-2\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/a7a0d3017fb58318083321994a81ffc0be78bc1c2c039df03c936c365bab39fb?s=96&d=mm&r=g","width":96,"height":96,"caption":"THANC Foundation"}},{"@type":"WebPage","@id":"https:\/\/tiro.expert\/es\/2025\/07\/unresectable-vs-resectable-thyroid-cancer-pt-2\/#webpage","url":"https:\/\/tiro.expert\/es\/2025\/07\/unresectable-vs-resectable-thyroid-cancer-pt-2\/","name":"Unresectable vs. Resectable Thyroid Cancer (Pt. 2) \u2023 TIRO","description":"What changes when thyroid tumors once considered inoperable become surgical candidates? Dr. Mark Zafereo joins Dr. Dana Hartl to explore how neoadjuvant therapy reshapes surgical timing, decision-making, and long-term care for patients with aggressive thyroid cancer. This discussion uncovers clinical judgment calls, imaging insights & evolving surgical strategies you won't want to miss.","inLanguage":"es-MX","isPartOf":{"@id":"https:\/\/tiro.expert\/es\/#website"},"breadcrumb":{"@id":"https:\/\/tiro.expert\/es\/2025\/07\/unresectable-vs-resectable-thyroid-cancer-pt-2\/#breadcrumblist"},"author":{"@id":"https:\/\/tiro.expert\/es\/author\/hncg2-admin\/#author"},"creator":{"@id":"https:\/\/tiro.expert\/es\/author\/hncg2-admin\/#author"},"datePublished":"2025-07-15T05:00:00-05:00","dateModified":"2025-07-15T05:00:00-05:00"},{"@type":"WebSite","@id":"https:\/\/tiro.expert\/es\/#website","url":"https:\/\/tiro.expert\/es\/","name":"TIRO","description":"Thyroid Int'l Recommendations Online","inLanguage":"es-MX","publisher":{"@id":"https:\/\/tiro.expert\/es\/#organization"}}]}},"aioseo_meta_data":{"post_id":"23775","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"seo_analyzer_scan_date":"2026-11-09 02:48:59","breadcrumb_settings":null,"limit_modified_date":false,"open_ai":null,"ai":null,"created":"2025-07-15 15:51:37","updated":"2026-11-09 02:48:59","focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"featured_image_src":null,"featured_image_src_square":null,"author_info":{"display_name":"THANC Foundation","author_link":"https:\/\/tiro.expert\/es\/author\/hncg2-admin\/"},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false,"gb-block-post-grid-landscape":false,"gb-block-post-grid-square":false,"post-thumbnail":false,"twentytwenty-fullscreen":false},"uagb_author_info":{"display_name":"THANC Foundation","author_link":"https:\/\/tiro.expert\/es\/author\/hncg2-admin\/"},"uagb_comment_info":0,"uagb_excerpt":"What changes when thyroid tumors once considered inoperable become surgical candidates? Dr. Mark Zafereo joins Dr. Dana Hartl to explore how neoadjuvant therapy reshapes surgical timing, decision-making, and long-term care for patients with aggressive thyroid cancer. This discussion uncovers clinical judgment calls, imaging insights &amp; evolving surgical strategies you won&#8217;t want to miss.","publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/tiro.expert\/es\/wp-json\/wp\/v2\/posts\/23775","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tiro.expert\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tiro.expert\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tiro.expert\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/tiro.expert\/es\/wp-json\/wp\/v2\/comments?post=23775"}],"version-history":[{"count":0,"href":"https:\/\/tiro.expert\/es\/wp-json\/wp\/v2\/posts\/23775\/revisions"}],"wp:attachment":[{"href":"https:\/\/tiro.expert\/es\/wp-json\/wp\/v2\/media?parent=23775"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tiro.expert\/es\/wp-json\/wp\/v2\/categories?post=23775"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tiro.expert\/es\/wp-json\/wp\/v2\/tags?post=23775"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}